跳转至内容

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
所有图片(1)

主要文件

05-753

Sigma-Aldrich

抗-WT1抗体,克隆6F-H2

clone 6F-H2, Upstate®, from mouse

别名:

Anti-AWT1, Anti-GUD, Anti-NPHS4, Anti-WAGR, Anti-WIT-2, Anti-WT-1, Anti-WT33

登录查看公司和协议定价

选择尺寸

1 L
¥974.30
2.5 L
¥2,047.88

¥974.30


预计发货时间2025年9月09日详情


获取大包装报价

选择尺寸

变更视图
1 L
¥974.30
2.5 L
¥2,047.88

About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

¥974.30


预计发货时间2025年9月09日详情


获取大包装报价

生物来源

mouse

质量水平

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

6F-H2, monoclonal

种属反应性

human

制造商/商品名称

Upstate®

技术

immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable

同位素/亚型

IgG1

NCBI登记号

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
320536808154447285
氯化亚砜 ReagentPlus®, ≥99%

230464

氯化亚砜

氯化亚砜 reagent grade, 97%

320536

氯化亚砜

亚硫酰氯 for synthesis

808154

亚硫酰氯

氯化亚砜 ReagentPlus®, 99.5%, low iron

447285

氯化亚砜

form

liquid

form

liquid

form

liquid

form

liquid

assay

≥99%

assay

97%

assay

-

assay

99.5%

Quality Level

200

Quality Level

100

Quality Level

200

Quality Level

100

density

1.631 g/mL at 25 °C (lit.)

density

1.631 g/mL at 25 °C (lit.)

density

1.64 g/cm3 at 20 °C

density

1.631 g/mL at 25 °C (lit.)

anion traces

chloride (Cl-): 59.0-60.2%

anion traces

-

anion traces

-

anion traces

-

mp

−105 °C (lit.)

mp

−105 °C (lit.)

mp

-104.5 °C

mp

−105 °C (lit.)

特异性

WT1

免疫原

6His标记融合蛋白,对应人WT1(维尔姆斯瘤)的1-181位残基。

应用

抗-WT1抗体(克隆6F-H2)是一种用于检测WT1(又称维尔姆斯瘤)的小鼠单克隆抗体,目前已通过WB、ICC & IHC应用验证。

质量

已通过免疫印迹对Jurkat和Raji细胞的RIPA裂解液进行常规评估

目标描述

55-60kDa

外形

形式:纯化

法律信息

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

储存分类代码

10 - Combustible liquids

WGK

WGK 1

  • 技术规格说明书

  • 分析证书(COA)

    输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

    请选择产品编号

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Kazunori Inoue et al.
    The Journal of clinical investigation, 129(3), 1295-1313 (2019-02-19)
    We identified 2 genes, histone deacetylase 1 (HDAC1) and HDAC2, contributing to the pathogenesis of proteinuric kidney diseases, the leading cause of end-stage kidney disease. mRNA expression profiling from proteinuric mouse glomeruli was linked to Connectivity Map databases, identifying HDAC1
    Chen Wu et al.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 8(9), 1163-1169 (2013-08-16)
    The Wilms' tumor gene (WT1) has been identified as an oncogene in many malignant diseases, and aberrant WT1 expression has been linked to development, progression, and prognosis of non-small-cell lung cancer (NSCLC). We sought to investigate the underlying mechanism of
    Zenglai Tan et al.
    Scientific reports, 8(1), 16618-16618 (2018-11-11)
    The kidney is a complex organ that is comprised of thousands of nephrons developing through reciprocal inductive interactions between metanephric mesenchyme (MM) and ureteric bud (UB). The MM undergoes mesenchymal to epithelial transition (MET) in response to the signaling from
    Toru Sakairi et al.
    American journal of physiology. Renal physiology, 298(3), F557-F567 (2009-12-04)
    Evidence suggests that loss of podocytes into urine contributes to development of glomerular diseases; shed podocytes are frequently viable and proliferate in culture conditions. To determine the phenotypic characteristics of viable urinary cells derived from human subjects, we established long-term
    Caihua Xu et al.
    PloS one, 8(8), e68837-e68837 (2013-08-13)
    The Wilms' tumor suppressor gene (WT1) has been identified as an oncogene in many malignant diseases such as leukaemia, breast cancer, mesothelioma and lung cancer. However, the role of WT1 in non-small-cell lung cancer (NSCLC) carcinogenesis remains unclear. In this

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持